List of Big Medical Stocks

Last Trade
Shares Out
Market Cap
US$ 501.48
-3.41 -0.68
US$ 193.550B
US$ 249.62
-4.84 -1.90
US$ 184.310B
US$ 98.93
-1.35 -1.35
US$ 172.140B
US$ 284.31
-4.66 -1.61
US$ 107.980B
US$ 80.46
-1.02 -1.25
US$ 107.010B
US$ 284.35
-7.61 -2.61
US$ 99.910B
US$ 53.98
-0.12 -0.22
US$ 78.810B
US$ 265.11
-2.02 -0.76
US$ 76.910B
US$ 70.18
-1.77 -2.46
US$ 42.660B
US$ 78.38
-1.80 -2.24
US$ 38.550B
US$ 199.17
-6.25 -3.04
US$ 36.470B
US$ 179.97
0.00 0.00
US$ 36.150B
US$ 89.08
-3.55 -3.83
US$ 34.550B
US$ 109.74
-2.73 -2.43
US$ 32.110B
US$ 374.47
-9.87 -2.57
US$ 27.660B
US$ 117.80
-2.51 -2.09
US$ 24.620B
US$ 1.00
-37.14 -3.28
US$ 23.910B
US$ 300.28
-9.22 -2.98
US$ 22.980B
US$ 89.09
-0.28 -0.31
US$ 22.330B
US$ 220.58
-4.69 -2.08
US$ 21.790B
US$ 133.33
-5.02 -3.63
US$ 21.110B
US$ 251.87
-9.91 -3.79
US$ 20.690B
US$ 136.33
-4.79 -3.39
US$ 20.050B
US$ 38.12
-0.35 -0.91
US$ 19.300B
US$ 205.19
-0.01 0.00
US$ 18.180B

Latest Big Medical Stocks News

Stryker's Triathlon Tritanium Baseplate marks a decade of positive patient impact

Over 1 million Triathlon Cementless Knees implanted globally MAHWAH, N.J., Sept. 21, 2023 /PRNewswire/ -- Stryker (NYSE: SYK), one of the world's leading medical technology companies, continues its year of milestones celebration with the 10th anniversary of the Triathlon Tritanium baseplate. Since its introduction in 2013, Triathlon Cementless, which includes the Triathlon Tritanium Baseplate, has delivered a decade of positive patient impact, demonstrated impressive... Read more

Medtronic Diabetes announces CE Mark for new Simplera™ CGM with disposable all-in-one design

The company's newest Simplera™ CGM is 50% smaller than its previous generation with a simple insertion and improved user experience DUBLIN, Sept. 21, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced CE (Conformité Européenne) Mark approval for its new all-in-one, disposable Simplera™ continuous glucose monitor (CGM) featuring a simple, two-step insertion process. The company's newest no-fingerstick... Read more

Abbott Broadens Access to Cutting-Edge Biosimilars in Key Emerging Markets

Abbott to commercialize several biosimilar molecules in key emerging markets in Latin America, Southeast Asia, the Middle East and Africa Spain-based global biotech leader mAbxience Holdings S.L. to develop, manufacture and supply the biosimilar molecules First molecules expected to launch as early as 2025, offering new treatment options that leverage the latest in scientific breakthroughs for people in emerging markets ABBOTT PARK, Ill., Sept. 20, 2023 /PRNewswire/... Read more

ICON Releases Expanded End-to-end Clinical Trial Tokenisation Solution

Solution seamlessly delivers proprietary technology, real world data and analytics, aligning to industry security and data privacy standards DUBLIN / Sep 20, 2023 / Business Wire / ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announces the release of its next generation Clinical Trial Tokenisation solution. The combination of ICON’s proprietary tokenisation engine, access to real-world data and advanced... Read more

Stryker Launches PROstep® MIS Lapidus, a New Minimally Invasive Surgical Option for Treating Patients with Bunions

Stryker’s PROstep MIS portfolio will be featured at the American Orthopaedic Foot & Ankle Society Annual Meeting KALAMAZOO, Mich. / Sep 19, 2023 / Business Wire / Stryker (NYSE: SYK), one of the world’s leading medical technology companies, announced the launch of PROstep® MIS Lapidus, a new internal fixation system intended for treating bunions using a minimally invasive surgical reduction of hallux valgus deformity and subsequent fusion of the first metatarsal... Read more

Danaher to Provide Cepheid's Tuberculosis Test to the Global Fund at Cost

New agreement aims to provide greater access to millions more high-quality tuberculosis (TB) tests for people living in the least developed countries where the need is most urgent. Enables the Global Fund to provide Cepheid's Xpert® MTB/RIF Ultra diagnostic test cartridges for TB at cost, with no profit to Danaher. WASHINGTON, Sept. 19, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher"), a global science and technology innovator, today announced it... Read more

Boston Scientific Announces Agreement to Acquire Relievant Medsystems

Acquisition intended to expand neuromodulation portfolio to provide more treatment options for people living with chronic low back pain MARLBOROUGH, Mass., Sept. 19, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Relievant Medsystems, Inc., a privately held medical technology company that has developed and commercialized the Intracept® Intraosseous Nerve Ablation System to treat... Read more

Abbott and WeightWatchers Connected App Experience is Now Available for People Living with Diabetes

The #1 prescribed continuous glucose monitoring (CGM) system1 now connects to the #1 doctor-recommended weight management plan2 to help people living with diabetes understand how food and activity impact their glucose levels WeightWatchers Diabetes-Tailored Plan members can now see key glucose data3,4,5 from Abbott's FreeStyle Libre® 2 system within the WW app6 ABBOTT PARK, Ill. and NEW YORK, Sept. 19, 2023 /PRNewswire/ -- Abbott (NYSE: ABT) and WW International,... Read more

Canadian First - Abbott's TactiFlex™ Ablation Catheter Used to Treat AFib

Abbott introduced the world's first ablation catheter with a flexible tip and contact force technology, used to perform an ablation procedure to treat atrial fibrillation (AFib) First successful treatment in Canada - Abbott's innovative technology enables physicians to have better visualization allowing for more accuracy and precision, leading to reduced procedure times and better safety MISSISSAUGA, ON, Sept. 19, 2023 /CNW/ -- Abbott (NYSE: ABT) today announced that... Read more

A Clearer Vision of Surgery: Stryker Releases its Next-Generation of Advanced Surgical Cameras

Stryker's 1788 camera platform brings enhanced technology to the operating room – including a wider color gamut, more vivid white light and new fluorescence imaging capabilities SAN JOSE, California, USA, Sept. 14, 2023 /PRNewswire/ -- Stryker (NYSE: SYK), one of the world's leading medical technology companies, today unveiled the next-generation of minimally invasive surgical cameras: the 1788 platform. The fully enhanced camera is set to advance surgery across... Read more

Labcorp to Present Strategy, Business and Financial Outlook at Investor Day

BURLINGTON, N.C., Sept. 14, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, is hosting an Investor Day beginning at 1:00 p.m. ET today in New York City, expected to conclude by approximately 4:00 p.m. ET. The event will highlight the company's go-forward strategy from Labcorp Chairman & CEO Adam Schechter, followed by business overviews and a longer-term financial outlook by members of the leadership... Read more

BARDA Partners With ICON to Execute Next Generation COVID-19 Vaccines Clinical Trial

DUBLIN / Sep 13, 2023 / Business Wire / ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announces that it is partnering with the U.S. Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, to execute a clinical trial to evaluate the effectiveness of next generation COVID-19 vaccine... Read more

Stryker’s Pangea Systems Receive FDA Clearance

Pangea to offer a comprehensive and versatile portfolio, providing variable-angle plating for a variety of patient populations KALAMAZOO, Mich. / Sep 12, 2023 / Business Wire / Stryker (NYSE: SYK), one of the world’s leading medical technology companies, announced that its Pangea Systems including Femur, Fibula, Tibia, Humerus and Utility have received 510k clearance from the U.S. Food & Drug Administration. “FDA clearance is a critical milestone for our Pangea... Read more

Agilent Technologies and Exact Sciences Agree to Terms of Sale for Resolution Bioscience

Resolution Bioscience’s blood-based diagnostic tests complement Exact Sciences’ Precision Oncology portfolio, providing a more complete cancer treatment solution for patients, healthcare professionals, and biopharma partners SANTA CLARA, Calif. & MADISON, Wis. / Sep 12, 2023 / Business Wire / Agilent Technologies, Inc. (NYSE: A) and Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced they have entered... Read more

Cataract Surgery with Alcon’s AcrySof IQ Vivity IOLs Demonstrates Sustained High Patient Satisfaction and Reduced Spectacle Dependence

Alcon Vivity Registry continues to demonstrate excellent outcomes with AcrySof IQ Vivity and AcrySof IQ Vivity Toric, the first and only PCIOL+ with wavefront-shaping technology World-renowned surgeons will present new registry data at #ESCRS2023, including data on rates of visual disturbances1,2 Registry monitored 900+ cataract patients post-surgery, including those with certain mild comorbidities GENEVA / Sep 09, 2023 / Business Wire / Alcon (SIX/NYSE: ALC), the... Read more

Navigate BioPharma Services Announces Collaboration with BD (Becton, Dickinson and Company) to Advance Capabilities for Clinical Phases of Drug Development

CARLSBAD, Calif., Sept. 7, 2023 /PRNewswire/ -- Navigate BioPharma Services, Inc., a specialty laboratory offering high-quality, innovative precision medicine solutions and bioanalytics for clinical development and diagnostic applications, announces a strategic collaboration with BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, to explore opportunities to develop and commercialize flow cytometry-based companion diagnostics... Read more

Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device

New stroke risk reduction therapy with thromboresistant coating is designed to advance procedural performance and safety MARLBOROUGH, Mass., Sept. 6, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Drug Administration approval for the latest-generation WATCHMAN FLX™ Pro Left Atrial Appendage Closure (LAAC) Device. Designed to further advance the procedural performance and safety of the WATCHMAN technology,... Read more

Align Technology Introduces Invisalign® System Innovation for Greater Control of Digital Treatment Planning With Integration of Plan Editor Into ClinCheck® Treatment Planning Software

Plan Editor is a new tool in the Plan stage of the Align digital workflow that enables enhanced flexibility and customization in Invisalign treatment planning for Invisalign trained orthodontists and general practitioner (GP) dentists. Complements Align’s automated treatment planning templates, allowing doctors to quickly make broad, macro modification, exceptions, or to deviate, if needed, from their treatment planning templates for a specific patient. With ClinCheck®... Read more

Align Technology to Acquire Privately Held Direct 3D Printing Pioneer Cubicure to Support and Scale Company’s Strategic Innovation Roadmap

LAS VEGAS & SAN JOSE, Calif. & TEMPE, Ariz. & VIENNA / Sep 06, 2023 / Business Wire / Align Technology, Inc. (Align) (Nasdaq: ALGN) today announced that it has entered into a definitive agreement to acquire privately held Cubicure GmbH, a pioneer in direct 3D printing solutions for polymer additive manufacturing that develops, produces, and distributes innovative materials, equipment, and processes for novel 3D printing solutions. Cubicure’s patented Hot Lithography... Read more

Align Technology Introduces New Software Innovations Designed to Accelerate Digital Practice Transformation

AlignTM Oral Health Suite including future collaboration with X-Ray Insights will Aid Doctors in Identifying and Educating Patients on Oral Health Conditions and Improve Their Oral Health iTero-exocad ConnectorTM Upcoming Release Will Optimize Doctor and Lab Collaboration and Productivity by Streamlining Case Communication in a Single Channel on the MyiTeroTM Portal LAS VEGAS & PETACH TIKVA, Israel & SAN JOSE, Calif. & TEMPE, Ariz.. / Sep 06, 2023 / Business... Read more

Abbott to Acquire Bigfoot Biomedical, Furthering Efforts to Develop Personalized, Connected Solutions for People with Diabetes

Bigfoot developed Bigfoot Unity, a smart insulin management system that features the first and only FDA-cleared connected insulin pen caps that turn data from a continuous glucose monitor (CGM) into clear and reliable insulin dosing recommendations displayed right on the insulin pen cap Acquisition will bring together two leaders in different aspects of diabetes care: CGM and insulin injection support Together, Abbott and Bigfoot will continue to advance technology-driven... Read more

Illumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer

SAN DIEGO, Sept. 5, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its Board of Directors has appointed Jacob Thaysen, Ph.D., senior vice president of Agilent Technologies and president of its Life Sciences and Applied Markets Group, as Chief Executive Officer, effective September 25, 2023. Mr. Thaysen's extensive background and experience in genomics, life sciences, and technology... Read more

Cardinal Health Launches Next Generation Medical Device to Improve Neonatal Feeding

The NTrainer™ System 2.0 is the only FDA Class II biofeedback device designed to help newborns and infants born prematurely develop their non-nutritive sucking skills needed for independent oral feeding.  DUBLIN, Ohio, Aug. 30, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today the launch of its next generation NTrainer™ System 2.0, a medical device designed to help premature and newborn infants develop the oral coordination skills important... Read more

Danaher to Acquire Abcam

WASHINGTON, Aug. 28, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher" or the "Company"), a global science and technology innovator, announced today that it has entered into a definitive agreement to acquire Abcam plc (NASDAQ: ABCM), a leading global supplier of protein consumables, pursuant to which Danaher will acquire all of the outstanding shares of Abcam for $24.00 per share in cash, or a total enterprise value of approximately $5.7 billion including... Read more

Edwards Lifesciences To Present At The 2023 Wells Fargo Healthcare Conference

IRVINE, Calif., Aug. 28, 2023 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) today announced it is scheduled to present at the 2023 Wells Fargo Healthcare Conference on Thursday, September 7, 2023.  Bernard Zovighian, chief executive officer, and Scott B. Ullem, chief financial officer, are scheduled to speak to conference attendees at 11:00 a.m. ET. A live webcast of the presentation will be available to all interested parties on the Edwar... Read more

Dexcom Appoints Rimma Driscoll to Board of Directors

SAN DIEGO / Aug 28, 2023 / Business Wire / DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring, today announced the appointment of Rimma Driscoll to its Board of Directors, effective August 24, 2023. Ms. Driscoll is an accomplished leader with significant experience developing, guiding and executing organic and inorganic growth strategies for global organizations. She currently serves as Executive Vice President and Head of Global Strategy,... Read more

Boston Scientific : ADVENT Study of the FARAPULSE™ Pulsed Field Ablation System Meets Primary Efficacy and Safety Endpoints

Noninferiority established through high treatment success, low adverse event rates Findings presented at ESC Congress 2023 and simultaneously published in The New England Journal of Medicine MARLBOROUGH, Mass. and AMSTERDAM, Aug. 27, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced positive 12-month results from the pivotal ADVENT clinical trial of the FARAPULSE™ Pulsed Field Ablation (PFA) System*, a nonthermal treatment in which electric... Read more

Medtronic receives CE Mark approval for Inceptiv™ spinal cord stimulator with closed-loop sensing to treat chronic pain

Inceptiv automatically and instantly adjusts therapy based on signals from the spinal cord DUBLIN, Aug. 25, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, has received CE (Conformité Européenne) Mark approval for its Inceptiv™ closed-loop rechargeable spinal cord stimulator (SCS). It is the first Medtronic SCS device to offer a closed-loop feature that senses each person's unique biological signals and adjusts stimulation... Read more

Agilent Technologies Receives European IVDR Certification for Companion Diagnostic Assay

SANTA CLARA, Calif. / Aug 24, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced the issuing of a companion diagnostic (CDx) Class C IVDR certification for PD-L1 IHC 22C3 pharmDx, Code SK006. This CDx assay has previously been CE-IVD–marked for sales in the European Union and is now certified in accordance with the new EU Regulation for in vitro diagnostic medical devices (IVDR). PD-L1 IHC 22C3 pharmDx, Code SK006, is indicated as an aid in identifying... Read more

Advent International and Warburg Pincus Name Franco Negron CEO of BioPharma Solutions Following its Proposed Divestiture from Baxter

BOSTON and NEW YORK, Aug. 24, 2023 /PRNewswire/ -- Advent International ("Advent"), one of the largest and most experienced global private equity investors, and Warburg Pincus, a leading global growth investor, today announced they have selected Franco Negron to be chief executive officer (CEO) of BioPharma Solutions (BPS) following its proposed divestiture from Baxter International Inc. (NYSE:BAX). The closing of the divestiture, which remains subject to the... Read more

Medtronic issues statement on the FDA Circulatory Systems Devices Advisory Panel vote for the Symplicity Spyral Renal Denervation System

DUBLIN, Aug. 23, 2023 /PRNewswire/ -- Today, Medtronic announced the outcome of the U.S. Food & Drug Administration (FDA) Circulatory System Devices Panel (CSDP) meeting to review data presented in support of the Medtronic Symplicity Spyral™ Renal Denervation (RDN) System. The panel Committee voted unanimously (13-0) on safety and in favor (7-6) of the effectiveness of the Symplicity blood pressure procedure. The Committee's vote was closely divided on the benefit/risk... Read more

Medtronic reports first quarter fiscal 2024 financial results

Broad strength across businesses and geographies results in mid-single digit revenue growth, driven by execution, innovation, and improved underlying fundamentals DUBLIN, Aug. 22, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT) today announced financial results for its first quarter of fiscal year 2024 (FY24), which ended July 28, 2023. Key Highlights Revenue of $7.7 billion increased 4.5% as reported and 6.0% organic GAAP diluted earnings per share (EPS) of $0.59... Read more

Illumina expands genomics capabilities in India with opening of Solutions Center

SAN DIEGO, Aug. 17, 2023 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the opening of a new office and state-of-the-art Illumina Solutions Center in Bengaluru, India. Illumina's expansion comes after 16 years of working closely with the company's channel partner in India, Premas Life Sciences. Now with its own permanent facility, Illumina will continue to collaborate with Premas to grow... Read more

Alcon Reports Second Quarter 2023 Results

Second quarter 2023 sales of $2.4 billion, up 9%, or 12% constant currency(1) (cc) Second quarter 2023 diluted EPS of $0.34, up 13%, or up 34% cc; core diluted EPS(2) of $0.69 up 10%, or 19% cc Based on strong operational performance and improved outlook, Company raises full year 2023 sales and core diluted EPS guidance GENEVA / Aug 15, 2023 / Business Wire / Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three and... Read more

Cardinal Health Reports Fourth Quarter and Full Year Results for Fiscal Year 2023 at High End of Investor Day Guidance

Fourth quarter revenue increased 13% to $53.5 billion Fourth quarter GAAP1 operating earnings were $137 million and GAAP diluted loss per share was $0.25 Fourth quarter non-GAAP operating earnings increased 24% to $560 million and non-GAAP diluted EPS increased 48% to $1.55 Fourth quarter Pharmaceutical segment profit increased 12% to $504 million and Medical segment profit increased to $82 million Generated both operating cash flow and non-GAAP adjusted free cash... Read more

AmerisourceBergen Elects Werner Baumann and Lauren Tyler to Its Board of Directors

CONSHOHOCKEN, Pa. / Aug 15, 2023 / Business Wire / AmerisourceBergen Corporation (NYSE: ABC) today announced that its Board of Directors has elected Werner Baumann and Lauren M. Tyler as new independent directors, effective October 1, 2023. With the election of Mr. Baumann and Ms. Tyler, the Board of Directors will increase from ten to twelve members, ten of whom are independent. “We look forward to welcoming Mr. Baumann and Ms. Tyler to AmerisourceBergen’s Board of... Read more

Thermo Fisher Scientific Completes Acquisition of CorEvitas

Advances World-Class Clinical Research Capabilities with Leading Regulatory-Grade Registries Platform Expected to Be Accretive to Adjusted Earnings Per Share1 WALTHAM, Mass. / Aug 14, 2023 / Business Wire / Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced that it has completed the acquisition of CorEvitas, LLC (“CorEvitas”), a leading provider of regulatory-grade, real-world evidence for approved... Read more

Illumina Reports Financial Results for Second Quarter of Fiscal Year 2023

Revenue of $1.18 billion for Q2 2023, up 1% from Q2 2022 (up 3% on a constant currency basis) and up 8% from Q1 2023 Shipped 109 NovaSeq X instruments in Q2 2023; boosting our supply capacity to more than 390 instruments for fiscal year 2023 GAAP diluted loss per share of $(1.48) for Q2 2023, compared to GAAP diluted loss per share of $(3.40) for Q2 2022, which included $609 million in legal contingencies Non-GAAP diluted earnings per share of $0.32 for Q2 2023, compared... Read more

Boston Scientific Receives FDA Approval for the POLARx™ Cryoablation System

First-of-its-kind expandable cryoballoon catheter advances cryoablation therapy, addresses key limitations with traditional systems MARLBOROUGH, Mass., Aug. 8, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Drug Administration (FDA) approval for the POLARx™ Cryoablation System. The new system, which is indicated for the treatment of patients with paroxysmal atrial fibrillation (AF), features the POLARx... Read more

ResMed Announces Results for the Fourth Quarter of Fiscal Year 2023

Year-over-year revenue grows 23%, operating profit up 8%, non-GAAP operating profit up 13% Quarterly dividend increases 9% to $0.48 per share A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, Aug. 03, 2023 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended June 30, 2023. Fourth Quarter 2023 HighlightsAll comparisons are to the... Read more

Stryker reports second quarter 2023 operating results

Kalamazoo, Michigan, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the second quarter of 2023: Second Quarter Results Reported net sales increased 11.2% to $5.0 billion Organic net sales increased 11.9% Reported operating income margin of 19.3% Adjusted operating income margin(1) increased 60 bps to 24.3% Reported EPS increased 12.2% to $1.93 Adjusted EPS(1) increased 12.9% to $2.54   Second Quarter Net Sales... Read more

Becton Dickinson Reports Third Quarter Fiscal 2023 Financial Results

Continues Strong Performance and Progress Toward Achieving BD 2025 Strategy; Advances Innovation Pipeline and Receives Clearance for Updated BD Alaris™ Infusion System Revenue of $4.9 billion increased 5.1% as reported and 6.3% on a currency-neutral basis Revenue from base business (which excludes COVID-only diagnostic testing) grew 6.7% as reported, 7.9% currency-neutral or 6.3% organic GAAP and adjusted diluted EPS from continuing operations of $1.36 and $2.96,... Read more

Labcorp Forges Strategic Partnership with Tufts Medicine, Will Acquire Outreach Laboratory Business

Labcorp Expands Diagnostic Testing and Laboratory Services in Eastern Massachusetts to Increase Access, Affordability and Standardized Testing Labcorp and Tufts Medicine have entered into an agreement for Labcorp to acquire the Tufts Medicine Outreach Laboratory Business and select operating assets This transaction – an initial component of an envisioned larger strategic partnership – will expand patient specimen collection access in the locations and diverse... Read more

McKesson Reports Fiscal 2024 First Quarter Results

IRVING, Texas / Aug 02, 2023 / Business Wire / McKesson Corporation (NYSE: MCK) has released its fiscal 2024 first quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Wednesday, August 2nd at 4:30 PM ET to review its financial results. The audio webcast of the conference... Read more

STERIS Completes the Acquisition of Surgical Instrumentation Assets from Becton Dickinson

DUBLIN, IRELAND, Aug. 02, 2023 (GLOBE NEWSWIRE) --  STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that it has completed the previously announced acquisition of the surgical instrumentation, laparoscopic instrumentation and sterilization container assets from BD (Becton, Dickinson and Company) (NYSE:BDX). “We are pleased to announce the closing of this acquisition, as the brands we are adding will strengthen, complement and expand STERIS’s... Read more

AmerisourceBergen Reports Fiscal 2023 Third Quarter Results

Revenue of $66.9 billion for the Third Quarter, an 11.5 Percent Increase Year-Over-Year Third Quarter GAAP Diluted EPS of $2.35 and Adjusted Diluted EPS of $2.92 Adjusted Diluted EPS Guidance Range Raised to $11.85 to $11.95 for Fiscal 2023 Company will begin operating as Cencora and trading under the ticker symbol “COR,” effective August 30, 2023 CONSHOHOCKEN, Pa. / Aug 02, 2023 / Business Wire / AmerisourceBergen Corporation (NYSE: ABC) today reported that in... Read more

STERIS Announces Financial Results for Fiscal 2024 First Quarter

First quarter revenue growth of 11% as reported and constant currency organic As reported diluted earnings per share increased to $1.25; adjusted earnings increased to $2.00 Fiscal 2024 outlook updated to reflect acquisition of BD surgical instrumentation assets DUBLIN, IRELAND, Aug. 01, 2023 (GLOBE NEWSWIRE) --  STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2024 first quarter ended June 30, 2023.... Read more

IQVIA Reports Second-Quarter 2023 Results

Revenue of $3,728 million grew 5.3 percent year-over-year on a reported basis and 5.5 percent at constant currency GAAP Net Income of $297 million grew 16.0 percent year-over-year Adjusted EBITDA of $864 million grew 8.0 percent year-over-year GAAP Diluted Earnings per Share of $1.59 grew 18.7 percent year-over-year Adjusted Diluted Earnings per Share of $2.43 declined 0.4 percent year-over-year R&D Solutions quarterly bookings of $2.7 billion, representing book-to-bill... Read more

IDEXX Laboratories Announces Second Quarter Results

Records second quarter revenue growth of 10% reported and 10% organic, driven by CAG Diagnostics recurring revenue growth of 11% reported and 12% organic Achieves record second quarter global premium instrument placements, supporting 11% annual installed base growth Delivers EPS of $2.67, representing 71% growth as reported and 77% on a comparable basis, including 54% of EPS growth rate benefit from lapping of discrete R&D investments in the second quarter... Read more

Becton Dickinson Receives 510(k) Clearance for COVID-19, Influenza A/B, RSV Molecular Combination Test

Single Test on BD MAX™ System Identifies and Differentiates Multiple Respiratory Infectious Diseases from One Sample FRANKLIN LAKES, N.J., Aug. 1, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the BD Respiratory Viral Panel (RVP) for BD MAX™ System, a single molecular diagnostic combination test that identifies and... Read more